Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
Sponsor: Novo Nordisk A/S
Summary
This clinical study is testing two versions of the study medicine cagrilintide. The purpose of the study is to compare these two versions to understand their effects in participants with overweight or obesity. Participants will receive either cagrilintide version D or cagrilintide version B, and which treatment participants receive is decided by chance. Participants will be in this clinical study for about 6 months.
Official title: Bioequivalence Study of Cagrilintide B + Placebo Semaglutide I and Cagrilintide D Once Weekly in Participants With Overweight or Obesity
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
234
Start Date
2026-05-18
Completion Date
2027-06-01
Last Updated
2026-06-26
Healthy Volunteers
No
Conditions
Interventions
Cagrilintide D
Cagrilintide D will be administered subcutaneously.
Cagrilintide B and placebo semaglutide I
Cagrilintide B and placebo semaglutide I will be administered subcutaneously
Locations (1)
Parexel International GmbH
Berlin, Germany